Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gradual Diltiazem Infusion as an Approach to Initial Rate Control in Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response in the Emergency Setting

NCT04141553 is registered in ClinicalTrials.gov with Mercy Health Muskegon as lead sponsor.

NCT NCT04141553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04141553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gradual Diltiazem Infusion as an Approach to Initial Rate Control in Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Response in the Emergency Setting
Lead sponsor
Mercy Health Muskegon
Phase
Phase 4
Overall status
Unknown status
Start date
December 1, 2019
Completion date
December 1, 2021
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial flutter, rapid ventricular response